Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Minneapolis, Minnesota 55415


Purpose:

To study the safety and efficacy of early administration of Low Molecular Weight Heparin to patients with traumatic brain injury.


Study summary:

Venous thromboembolic (VTE) prophylaxis in trauma patients is a critical clinical problem. Patients with traumatic brain injury usually have effective VTE prophylaxis withheld secondary to concerns of exacerbating intracranial hemorrhage. This study examines the safety and efficacy of early administration (within 24 hrs of admission) of low molecular weight heparin to this patient population with very high VTE risk.


Criteria:

Inclusion Criteria: - Blunt traumatic brain injury (Marshall II-V) - Stable 6 hr. head CT - Stable hemoglobin Exclusion Criteria: - Premorbid coagulopathy - Pregnancy - < 18 y.o. - Need for therapeutic anticoagulation - Heparin allergy


NCT ID:

NCT00170378


Primary Contact:

Principal Investigator
John K. Cumming, M.D.
Hennepin County Medical Center/MinneapolisMRF


Backup Contact:

N/A


Location Contact:

Minneapolis, Minnesota 55415
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.